Lataa...
Topical rapamycin (sirolimus) for facial angiofibromas
Rapamycin (sirolimus) is a fungal fermentation product that inhibits the proper functioning of a serine/threonine protein kinase in mammalian cells eponymously named mammalian target of rapamycin, or mTOR. Rapamycin is a novel class of anticancer and immunosuppressant drugs targeting the proteins at...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Medknow Publications & Media Pvt Ltd
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3573457/ https://ncbi.nlm.nih.gov/pubmed/23439391 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2229-5178.105488 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|